GeneOne Diagnostics Corporation has excellent R&D and independent production capabilities in vitro diagnostic reagents.In response to market demand, rapid development of diagnostic reagents and rapid screening reagents; in the early stage of the outbreak of the COVID-19, manpower was immediately invested in the development, and in a short period of time, Taiwan's EUA (Emergency Use Authorization, EUA) and CE certification was obtained.
In addition to its own R&D capacity, we can also be produced in accordance with customer needs. The product items range from research-use Molecular Biology reagents and IVD (In Vitro Diagnostic Devices, IVD), and all provide OEM and ODM services.